No. The CMS recently updated an FAQ to provide more clarification on this topic, and in many circumstances reporting is not required. The entire FAQ can be viewed here.
As a CME stakeholder or pharmaceutical manufacturer, do I have to report transfer of value in every situation?
Weekly Compliance Tip
Can trade names be mentioned to provide important background on treatment approaches for a specific condition (not to push a current treatment recommendation)?
The ACCME does not prohibit any use of trade names, but… More >
Contact
Phone: (303) 557-0859
E-mail: inquire@aoeconsulting.com
AOE Consulting, LLC
8156-E S. Wadsworth Blvd.
Suite 198
Littleton, CO 80128
